These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20378496)

  • 21. Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases.
    Neumann UP; Thelen A; Röcken C; Seehofer D; Bahra M; Riess H; Jonas S; Schmeding M; Pratschke J; Bova R; Neuhaus P
    Surgery; 2009 Jul; 146(1):52-9. PubMed ID: 19541010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: preliminary data and future perspectives.
    Adamo V; Franchina T; Minciullo PL; Pace E; Colonese F; Ricciardi GR; Saitta S; Ferraro M; Spatari G; Gangemi S
    J Cell Physiol; 2011 Nov; 226(11):3032-4. PubMed ID: 21302302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case report of complete remission of liver metastases from colorectal cancer treated with continuous hepatic arterial infusion].
    Tokunaga T; Sumimura J; Yoshidome K; Fujita S; Tsuji K; Oota F; Tsuboyama N; Nagai I
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):1009-11. PubMed ID: 12894720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimum chemotherapy regimens for neoadjuvant therapy of hepatic colorectal metastases.
    Davies JM; Goldberg RM
    J Surg Oncol; 2010 Dec; 102(8):946-54. PubMed ID: 21165997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatic artery infusion chemotherapy to three liver metastasis cases in which systemic chemotherapy was impossible or ineffective].
    Ando K; Oki E; Kakeji Y; Sugiyama M; Saeki H; Endo K; Morita M; Emi Y; Maehara Y
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2192-4. PubMed ID: 19106567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot randomized control trial of proglumide (a gastrin receptor antagonist) in advanced colorectal cancer.
    Morris DL; Charnley RM; Ballantyne KC; Jones J
    Eur J Surg Oncol; 1990 Oct; 16(5):423-5. PubMed ID: 2209837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radical surgery and loco-regional chemotherapy in the treatment of liver metastases of stomach and colorectal cancer].
    Di Giorgio A; Picchiotti R; Puntillo G; Barillari P; Al Mansour M; Flammia M; Galati G; Tocchi A
    Minerva Chir; 1989 Oct; 44(19):2065-71. PubMed ID: 2559364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
    Reddy SK; Tsung A; Marsh JW; Geller DA
    J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment advances in liver-limited metastatic colorectal cancer.
    Alberts SR; Poston GJ
    Clin Colorectal Cancer; 2011 Dec; 10(4):258-65. PubMed ID: 21820974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro schedule-dependent interaction between melphalan and oxaliplatin in human colorectal cancer cell lines.
    van Iersel LB; Koudijs TM; Hoekman EJ; Janssen-van Rhijn CM; Vahrmeijer AL; Nortier JW; van de Velde CJ; Gelderblom H; Kuppen PJ
    J Surg Res; 2011 May; 167(2):273-8. PubMed ID: 20036390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metastatic colorectal carcinoma: clinicopathological downstaging following neoadjuvant chemotherapy.
    Janes S
    N Z Med J; 2005 Feb; 118(1210):U1321. PubMed ID: 15776097
    [No Abstract]   [Full Text] [Related]  

  • 32. [Assessment of serial carcinoembryonic antigen (CEA): monitor to evaluate efficacy of continuous intrahepatic chemotherapy for nonresectable liver metastases of colorectal carcinomas].
    Yasuno M; Mori T; Takahashi K
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1556-9. PubMed ID: 7574758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer.
    Conroy T; Marchal F; Briançon S
    N Engl J Med; 2000 May; 342(20):1525; author reply 1526-7. PubMed ID: 10819650
    [No Abstract]   [Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy for patients with liver metastases from colorectal cancer.
    Mandalà M; Mosconi S; Quadri A; Milesi L; Labianca R
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):887-97. PubMed ID: 17555399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biochemically modulated chemotherapy with high-dose L-leucovorin and 5-fluorouracil for multiple liver metastasis from colorectal cancer].
    Konishi K; Yabushita K; Takada O; Kawamura T; Hasebe K; Tsugawa K; Maeda K; Kuroda Y; Tsuji M; Demachi H
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):961-4. PubMed ID: 7794005
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical efficacy of chemotherapy combined with verapamil in metastatic colorectal patients.
    Liu Y; Lu Z; Fan P; Duan Q; Li Y; Tong S; Hu B; Lv R; Hu L; Zhuang J
    Cell Biochem Biophys; 2011 Nov; 61(2):393-8. PubMed ID: 21562945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?
    Adam R; Wicherts DA; de Haas RJ; Aloia T; Lévi F; Paule B; Guettier C; Kunstlinger F; Delvart V; Azoulay D; Castaing D
    J Clin Oncol; 2008 Apr; 26(10):1635-41. PubMed ID: 18375892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
    Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
    Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of chemotherapy in managing patients with resectable liver metastases.
    Halfdanarson TR; Kendrick ML; Grothey A
    Cancer J; 2010; 16(2):125-31. PubMed ID: 20404609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling of liver metastatic disease with applied drug therapy.
    Filipovic N; Djukic T; Saveljic I; Milenkovic P; Jovicic G; Djuric M
    Comput Methods Programs Biomed; 2014 Jul; 115(3):162-70. PubMed ID: 24831076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.